Elisabeth C. Inwald

682 total citations
32 papers, 430 citations indexed

About

Elisabeth C. Inwald is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Elisabeth C. Inwald has authored 32 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Elisabeth C. Inwald's work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (6 papers) and Endometrial and Cervical Cancer Treatments (6 papers). Elisabeth C. Inwald is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (6 papers) and Endometrial and Cervical Cancer Treatments (6 papers). Elisabeth C. Inwald collaborates with scholars based in Germany, Austria and United Kingdom. Elisabeth C. Inwald's co-authors include Olaf Ortmann, Monika Klinkhammer‐Schalke, Ulrich Eysholdt, Michael Döllinger, Maria Schuster, Christopher Bohr, Michael Gerken, Susanne Schüler‐Toprak, Oliver Treeck and Michael Koller and has published in prestigious journals such as Breast Cancer Research and Treatment, BMC Cancer and Histopathology.

In The Last Decade

Elisabeth C. Inwald

30 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth C. Inwald Germany 10 167 77 75 64 60 32 430
Merete Ellingjord‐Dale Norway 12 225 1.3× 136 1.8× 27 0.4× 66 1.0× 57 0.9× 18 451
Mingyang Chen China 10 113 0.7× 41 0.5× 27 0.4× 30 0.5× 32 0.5× 33 374
Julia Sisti United States 12 202 1.2× 139 1.8× 44 0.6× 92 1.4× 110 1.8× 22 503
Jennifer Woo United States 6 136 0.8× 91 1.2× 17 0.2× 20 0.3× 30 0.5× 22 356
Lydia Choi United States 10 132 0.8× 85 1.1× 53 0.7× 36 0.6× 146 2.4× 21 430
Gebra Cuyún Carter United States 15 391 2.3× 171 2.2× 36 0.5× 24 0.4× 98 1.6× 50 797
Faïza Bessaoud France 14 148 0.9× 66 0.9× 38 0.5× 47 0.7× 56 0.9× 25 627
Luopei Wei China 9 270 1.6× 102 1.3× 52 0.7× 9 0.1× 110 1.8× 18 601
Ta Van To Vietnam 8 168 1.0× 171 2.2× 41 0.5× 109 1.7× 164 2.7× 11 496
Bin Nan United States 11 56 0.3× 95 1.2× 23 0.3× 90 1.4× 181 3.0× 21 633

Countries citing papers authored by Elisabeth C. Inwald

Since Specialization
Citations

This map shows the geographic impact of Elisabeth C. Inwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth C. Inwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth C. Inwald more than expected).

Fields of papers citing papers by Elisabeth C. Inwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth C. Inwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth C. Inwald. The network helps show where Elisabeth C. Inwald may publish in the future.

Co-authorship network of co-authors of Elisabeth C. Inwald

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth C. Inwald. A scholar is included among the top collaborators of Elisabeth C. Inwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth C. Inwald. Elisabeth C. Inwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schoffer, Olaf, Pauline Wimberger, Michael Gerken, et al.. (2024). Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer. Geburtshilfe und Frauenheilkunde. 84(2). 153–163. 6 indexed citations
2.
Schoffer, Olaf, Pauline Wimberger, Michael Gerken, et al.. (2024). Die Behandlung in zertifizierten Brustkrebszentren verbessert die Überlebenschancen von Patient*innen mit Brustkrebs. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 21(2). 121–131. 1 indexed citations
3.
Gerken, Michael, Péter Ugocsai, Elisabeth C. Inwald, et al.. (2024). Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer. Breast Cancer Research and Treatment. 204(3). 607–615. 3 indexed citations
4.
Voigtländer, Sven, Martin Radespiel‐Tröger, Elisabeth C. Inwald, et al.. (2023). Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany. Journal of Cancer Research and Clinical Oncology. 149(10). 7493–7503. 13 indexed citations
5.
6.
Gerken, Michael, Péter Ugocsai, Elisabeth C. Inwald, et al.. (2023). Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?. Journal of Cancer Research and Clinical Oncology. 149(13). 11941–11950. 3 indexed citations
7.
8.
Inwald, Elisabeth C., Monika Klinkhammer‐Schalke, Jacqueline Müller‐Nordhorn, et al.. (2022). Auswirkungen der COVID-19-Pandemie auf die Inzidenz und Therapie von Krebserkrankungen. Forum. 37(3). 198–203. 3 indexed citations
9.
Wesselmann, Simone, Clara Breidenbach, Jens‐Uwe Blohmer, et al.. (2021). Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers. Journal of Cancer Research and Clinical Oncology. 148(3). 719–726. 1 indexed citations
10.
11.
Scharl, Sophia, Michael Gerken, Anton Scharl, et al.. (2021). Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study. Archives of Gynecology and Obstetrics. 305(1). 203–213. 4 indexed citations
12.
Scharl, Anton, Atanas Ignatov, Olaf Ortmann, et al.. (2020). Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM® fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy. Journal of Cancer Research and Clinical Oncology. 147(6). 1813–1823. 9 indexed citations
13.
Papathemelis, Thomas, Anton Scharl, Michael Anapolski, et al.. (2020). Value of indocyanine green pelvic lymph node mapping in the surgical approach of cervical cancer. Archives of Gynecology and Obstetrics. 301(3). 787–792. 4 indexed citations
14.
15.
16.
Papathemelis, Thomas, Michael Gerken, Anton Scharl, et al.. (2019). Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer. Journal of Cancer Research and Clinical Oncology. 145(5). 1369–1376. 7 indexed citations
17.
18.
Schüler‐Toprak, Susanne, et al.. (2016). Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro. BMC Cancer. 16(1). 951–951. 49 indexed citations
19.
Skrzypczak, Maciej, Susanne Schüler‐Toprak, Florian Weber, et al.. (2015). Molecular profiling of estrogen receptor α and progesterone receptor transcript variants in endometrial cancer. Steroids. 104. 122–128. 12 indexed citations
20.
Inwald, Elisabeth C., Michael Döllinger, Maria Schuster, Ulrich Eysholdt, & Christopher Bohr. (2010). Multiparametric Analysis of Vocal Fold Vibrations in Healthy and Disordered Voices in High-Speed Imaging. Journal of Voice. 25(5). 576–590. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Merete Ellingjord‐Dale Breakdown of academic impact, for papers by Mingyang Chen Breakdown of academic impact, for papers by Julia Sisti Breakdown of academic impact, for papers by Jennifer Woo Breakdown of academic impact, for papers by Lydia Choi Breakdown of academic impact, for papers by Gebra Cuyún Carter Breakdown of academic impact, for papers by Faïza Bessaoud Breakdown of academic impact, for papers by Luopei Wei Breakdown of academic impact, for papers by Ta Van To Breakdown of academic impact, for papers by Bin Nan
Rankless by CCL
2026